Nevada Health and Bioscience Asset Corporation (EIN 843753195) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2019

Legal Domicile

Principal Officer

Lindy Schumacher

Phone

7024835705

Tax Period

2024-01-01 to 2024-12-31

Nevada Health and Bioscience Asset Corporation, founded in 2019, is a community nonprofit in the Education sector that reported $5.4M in total revenue in fiscal year 2024. Revenue fell 57% from the prior year — a significant decline worth monitoring. Expenses of $8.7M exceeded revenue, resulting in a 62% operating deficit.

Mission

Established for healthcare research, education and clinical programming, and asset development.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $3,244,985

Program Service Revenue $0

Investment Income $2,132,091

Other Revenue $0

TOTAL REVENUE $5,377,076

Expense Breakdown

Grants Paid $0

Salaries & Benefits $540,804

Fundraising Expenses $129,700

Program Expenses $7,816,964

Other Expenses $8,162,741

TOTAL EXPENSES $8,703,545

Year-over-Year Comparison

	2024	2023	Change
Revenue	$5,377,076	$12,613,457	-0.6%
Expenses	$8,703,545	$4,551,119	+0.9%
Net Income	$-3,326,469	$8,062,338	-1.4%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

Governance Policies

✓ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$183,551

Total Directors

$183,551

Key Employees

$202,904

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Maureen Schafer	CEO/President (Thru 03/24)	40.00	Officer Director	$177,516	$6,035	$183,551
James C Waddoups	CEO/President (From 04/24)	40.00	Officer	$0	$0	$0
Kris Engelstad McGarry	Secretary	0.50	Officer Director	$0	$0	$0
Lindy Schumacher	Treasurer	0.50	Officer Director	$0	$0	$0
Kim Case-Nichols	Chief Operating Officer	40.00	Key Emp	$195,100	$7,804	$202,904
John R Bailey	Director	0.10	Director	$0	$0	$0
MaryKaye Cashman	Director	0.10	Director	$0	$0	$0
Andrew Artusa	Director	0.10	Director	$0	$0	$0
Dr Anthony Marlon	Director (From 9/24)	0.10	Director	$0	$0	$0
Dr Robert McBeath	Director (From 9/24)	0.10	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$5,377,076	$8,703,545	$177,692,754	$-3,326,469
2023	$12,613,457	$4,551,119	$200,453,008	$8,062,338
2022	$41,321,073	$1,003,247	$160,599,179	$40,317,826
2021	$78,465,577	$944,776	$118,921,331	$77,520,801
2021	$78,465,577	$944,776	$133,437,634	$77,520,801
2020	$39,602,034	$829,172	$40,093,764	$38,772,862

Nevada Health and Bioscience Asset Corporation